Abridge AI vs Tempus AI
A detailed comparison to help you choose between Abridge AI and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Abridge AI at 3.7/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Abridge AI AI clinical conversation summarization | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 3.7 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $200/mo | From $1000/mo |
| Best For | Large Epic-based health systems with a procurement team and high documentation burden that want ambient AI notes written straight into the chart with sentence-level evidence. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | ssoteam features |
| Visit Abridge AI → | Visit Tempus AI → |
Abridge AI
Pros
- + Linked Evidence ties every note sentence to an audio timestamp, letting clinicians verify a draft in seconds
- + Deepest Epic integration in the category: embedded in Haiku, Canto, Hyperdrive and ASAP with bidirectional note sync
- + Documented at scale: Kaiser Permanente's rollout across 40 hospitals reported around 15,700 hours of documentation time saved in the study year
- + Covers 50-plus specialties with specialty-specific note structure and multi-language recognition
- + Best in KLAS for Ambient AI in both 2025 and 2026, with a peer-reviewed evidence base few competitors match
Cons
- - Enterprise-only: no self-serve signup, no individual plan, no public pricing page at all
- - Third-party cost estimates range widely, from roughly $2,500 to $7,200 per clinician per year, which makes budgeting guesswork
- - No FDA clearance and deliberately no clinical decision support: it documents, it does not reason
- - Epic-first; smaller EHRs such as eClinicalWorks or NextGen are not integrated
- - Mobile capture during the encounter is a workflow change some clinicians resist, per published deployment accounts
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Abridge AI or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 3.7/5 for Abridge AI, making it the better-rated option in our comparison.
What is the difference between Abridge AI and Tempus AI?▼
Abridge AI: AI platform that records patient-clinician conversations and generates structured clinical notes and summaries in real-time. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Abridge AI or Tempus AI more affordable?▼
Abridge AI starts at €200/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.